Found: 6
Select item for more details and to access through your institution.
The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0298864
- By:
- Publication type:
- Article
Cover Feature: Evaluation of Sydnone‐Based Analogues of Combretastatin A‐4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy (ChemMedChem 24/2018).
- Published in:
- ChemMedChem, 2018, v. 13, n. 24, p. 2600, doi. 10.1002/cmdc.201800768
- By:
- Publication type:
- Article
Evaluation of Sydnone‐Based Analogues of Combretastatin A‐4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy.
- Published in:
- ChemMedChem, 2018, v. 13, n. 24, p. 2618, doi. 10.1002/cmdc.201800567
- By:
- Publication type:
- Article
Cells Isolated from Umbilical Cord Tissue Rescue Photoreceptors and Visual Functions in a Rodent Model of Retinal Disease.
- Published in:
- Stem Cells, 2007, v. 25, n. 3, p. 602, doi. 10.1634/stemcells.2006-0308
- By:
- Publication type:
- Article
Preparation of Pre-Confluent Retinal Cells Increases Graft Viability In Vitro and In Vivo: A Mouse Model.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021365
- By:
- Publication type:
- Article
The influence of hypoxia and energy depletion on the response of endothelial cells to the vascular disrupting agent combretastatin A-4-phosphate.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66568-8
- By:
- Publication type:
- Article